Latest news
Loading news…
ProtaGene is a CRO partner for the biopharmaceutical, cell, and gene therapy industries.
ProtaGene was acquired by Ampersand Capital Partners in 2021 for $40M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
74
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Heilbronn, Baden-Wurttemberg, Germany
Acquisitions by ProtaGene
Loading columns…
0 of 0Show
Page 1 / 1
Key People at ProtaGene
Chief Executive Officer
74
professional contacts at ProtaGene
Contact execs at ProtaGene →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to ProtaGene
Loading news…
FAQs about ProtaGene
People who checked this page also checked these
Sectors ProtaGene invests & acquires in
Browse the full Acquirezy directory.